SEC Company Response from INVO Fertility, Inc. (IVF) (CIK 0001417926) (IVF) — Sep 12, 2019
INVO Fertility, Inc. (IVF) (CIK 0001417926)
Date: Sept. 12, 2019 · CIK: 0001417926 · Accession: 0001185185-19-001253
AI Filing Summary & Sentiment
Reasoning
Letter
VIA EDGAR AND FACSIMILE Securities and Exchange Commission Division of Corporation Finance Re: INVO Bioscience, Inc. (the “Company”) Registration Statement on Form S-1/A File No. 333- 228928 Request for Acceleration
Dear Mr. Fay:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:00 PM Eastern Standard Time on September 16, 2019, or as soon thereafter as is practicable. The Company herby acknowledges the following:
(i)
Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
(ii)
The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
(iii)
The Company may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Should you have further questions please contact our counsel, Scott D. Museles, at Shulman Rogers at (301) 230-5246. Thank you for your assistance in this matter.
Very truly yours,
INVO BIOSCIENCE, INC.
Show Raw Text
CORRESP 1 filename1.htm invobio20190912_corresp.htm INVO Bioscience, Inc. September 12, 2019 VIA EDGAR AND FACSIMILE Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Attn: Michael Fay Re: INVO Bioscience, Inc. (the “Company”) Registration Statement on Form S-1/A File No. 333- 228928 Request for Acceleration Dear Mr. Fay: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:00 PM Eastern Standard Time on September 16, 2019, or as soon thereafter as is practicable. The Company herby acknowledges the following: (i) Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; (ii) The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and (iii) The Company may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Should you have further questions please contact our counsel, Scott D. Museles, at Shulman Rogers at (301) 230-5246. Thank you for your assistance in this matter. Very truly yours, INVO BIOSCIENCE, INC. By: /s/ Kathleen T. Karloff Name: Kathleen T. Karloff Title: Chief Executive Officer